Businesses to delay new investment due to US tariffs, may trigger global slowdown: Nomura Report

Amid the ongoing tariff uncertainty by US President Donald Trump, businesses are likely to delay any new investment and this has the potential to trigger a global slowdown, according to a report by Nomura. The outlook for the global economy and financial markets remains highly uncertain as President Donald Trump’s aggressive tariff policy continues to…

Sun Pharma Q4 FY25 Results: PAT falls 19%, disappoints analysts; 550% dividend declared

Sun Pharma Q4 FY25 Earnings: Sun Pharma, a Mumbai-headquartered pharmaceutical giant, on Thursday reported a consolidated net profit of Rs 2,154 crore for the quarter ended March 31, missing analysts’ estimates. The quarterly net profit fell 19 per cent compared with the corresponding period a year ago, according to a regulatory filing.  The drug maker’s March-quarter…